Cite
HARVARD Citation
Kubota, K. et al. (2023). Reducing relapse through maintenance steroid treatment can decrease the cancer risk in patients with IgG4‐sclerosing cholangitis: Based on a Japanese nationwide study. Journal of gastroenterology and hepatology. 38 (4), pp. 556-564. [Online].